Abstract: A new Verbena plant particularly distinguished by large pink and white flowers, a semi-trailing plant habit, a high number of branches and medium vigor is disclosed.

Abstract: A new Verbena plant particularly distinguished by large pink, purple and white flowers, a semi-trailing growth habit, a high number of branches and medium vigor, is disclosed.

Abstract: A new Verbena plant particularly distinguished by large red-purple flowers, high flower richness, very tolerant to powdery mildew, and continuous flowering, is disclosed.

Abstract: A new Verbena plant particularly distinguished by large purple and white flowers, excellent flower richness, early flowering time, a strong growth habit and good resistance to powdery mildew, is disclosed.

Abstract: A new Verbena plant particularly distinguished by burgundy flowers and a semi-upright growth habit, is disclosed.

Abstract: A new and distinct variety of verbena plant named ‘KLEVP12449’, particularly characterized by a large flower with a white eye, a freely branching growth habit, and extremely good branching, is disclosed.

Abstract: A new variety of verbena named ‘KLEVP11419’, particularly characterized by having good flower quality, good branching, and flowers with large white eyes, is disclosed.

Abstract: The present invention relates to a compound of Formula I, or an isomer, pharmaceutically acceptable salt and solvate of the compound, and to a composition comprising the compound of Formula I, or the isomer, pharmaceutically acceptable salt and solvate thereof, and a pharmaceutically acceptable carrier, excipient or diluents. The present invention also relates to use of the compound of Formula I, or the isomer, pharmaceutically acceptable salt and solvate thereof for combating apoptosis, preventing or treating a disease or disorder associated with apoptosis; and especially use for protecting cardiomyocyte, and for preventing or treating a disease or disorder associated with cardiomyocyte apoptosis.

Abstract: The present invention relates to an acrylamide compound of Formula I, or an isomer, pharmaceutically acceptable salt and solvate thereof, to a composition comprising the compound or an isomer, pharmaceutically acceptable salt and solvate thereof, and a pharmaceutically acceptable carrier, excipient or diluent, and to a use of the compound or the composition for prophylaxis and/or treatment of a disease or disorder associated with cardiomyocyte apoptosis

Abstract: A compound of Formula I, or an isomer, pharmaceutically acceptable salt or solvate thereof, is provided. Also, a composition containing a compound of Formula I, or an isomer, pharmaceutically acceptable salt or solvate thereof, and a pharmaceutically acceptable carrier, excipient or diluents, is provided. Further, use of a compound of Formula I, or an isomer, pharmaceutically acceptable salt or solvate thereof for anti-apoptosis is provided, preventing or treating a disease or disorder associated with apoptosis; especially for protecting cardiomyocyte, preventing or treating a disease or disorder associated with cardiomyocyte apoptosis.

Abstract: A new variety of Verbena named ‘KLEVP10409’, particularly characterized by large flowers, good flower performance, freely center branching, and good mildew resistance, is disclosed.

Abstract: A new variety of Verbena named ‘KLEVP10407’, particularly characterized by large flowers, good center branching, and good mildew resistance, is disclosed.

Abstract: A new variety of Verbena named ‘KLEVP10410’, particularly characterized by brilliant white colored flowers, compact growth habit, good center branching, and good mildew resistance, is disclosed.

Abstract: A new variety of Verbena named ‘KLEVP10408’, particularly characterized by red purple colored petals, lighter at the tips, gradually getting darker towards the centers, and good mildew resistance, is disclosed.

Abstract: A new variety of Verbena named ‘KLEVP10414’, particularly characterized by having good flower performance, compact growth habit, very good branching, and good mildew resistance, is disclosed.

Abstract: A new variety of Verbena named ‘KLEVP11419’, particularly characterized by having good flower quality, good branching, and flowers with large white eyes, is disclosed.

Abstract: A new and distinct variety of Verbena plant named ‘KLEVP12446’, particularly characterized by having dark red flower color, a freely branching growth habit, and resistance to powdery mildew, is disclosed.

Abstract: A new and distinct variety of Verbena plant named ‘KLEVP12449’, particularly characterized by a large flower with a white eye, a freely branching growth habit, and extremely good branching, is disclosed.

Abstract: A new Verbena plant particularly distinguished by burgundy flowers and a semi-upright growth habit, is disclosed.

Abstract: A new Verbena plant particularly distinguished by large pink and white flowers, a semi-trailing plant habit, a high number of branches and medium vigor is disclosed.